These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29517661)

  • 1. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance.
    Peng S; Huang P; Yu H; Wen Y; Luo Y; Wang X; Zhou J; Qin S; Li T; Chen Y; Liu G; Huang M
    Medicine (Baltimore); 2018 Mar; 97(10):e0044. PubMed ID: 29517661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-glutamyl transferase to aspartate aminotransferase ratio (GSR) predicts prognoses in patients with colorectal cancer with liver metastasis after microwave ablation.
    Huang M; Chen Z; Qin S; Zhou J; Huang Y; Peng S; Huang P; Lin Y; Alenzi M; Huang J; Lin J; Chen Z; Huang M; Liu G
    BMC Gastroenterol; 2024 Sep; 24(1):327. PubMed ID: 39350076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of carcinoembryonic antigen (CEA) density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases.
    Huo YR; Glenn D; Liauw W; Power M; Zhao J; Morris DL
    Eur Radiol; 2017 Jan; 27(1):128-137. PubMed ID: 27165139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications?
    Sasaki K; Margonis GA; Andreatos N; Wilson A; Gani F; Amini N; Pawlik TM
    HPB (Oxford); 2016 Dec; 18(12):1000-1009. PubMed ID: 27769662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of liver thermal ablation in patients with hepatocellular carcinoma and colorectal cancer liver metastasis regarding spatial features and tumor-specific variables.
    Akhan O; Erdemir AG; Karahan S; Ünal E; Çiftçi TT; Akıncı D; Yalçın Ş
    Diagn Interv Radiol; 2024 May; 30(3):183-192. PubMed ID: 36994643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis.
    Okazaki S; Baba H; Iwata N; Yamauchi S; Sugihara K
    Surg Today; 2017 Oct; 47(10):1223-1229. PubMed ID: 28439715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases.
    Neofytou K; Giakoustidis A; Neves MC; Morrison D; Giakoustidis D; Khan AZ; Stebbing J; Mudan S
    Langenbecks Arch Surg; 2017 Jun; 402(4):599-605. PubMed ID: 27043945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important.
    Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP
    Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases.
    Correa-Gallego C; Fong Y; Gonen M; D'Angelica MI; Allen PJ; DeMatteo RP; Jarnagin WR; Kingham TP
    Ann Surg Oncol; 2014 Dec; 21(13):4278-83. PubMed ID: 24889486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.
    van Tilborg AA; Scheffer HJ; de Jong MC; Vroomen LG; Nielsen K; van Kuijk C; van den Tol PM; Meijerink MR
    Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1438-46. PubMed ID: 27387188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases.
    Krul MF; Gerritsen SL; Vissers FL; Klompenhouwer EG; Ruers TJ; Kuhlmann KF; Kok NF
    Eur J Surg Oncol; 2022 Apr; 48(4):834-840. PubMed ID: 34686404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and prognostic factors after pulmonary metastasectomy in patients with colorectal cancer with previously resected hepatic metastases.
    Shimizu K; Ohtaki Y; Okumura T; Boku N; Horio H; Takenoyama M; Yamashita M; Hyodo I; Mori K; Kondo H
    J Thorac Cardiovasc Surg; 2019 May; 157(5):2049-2057.e1. PubMed ID: 30745042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen half-life is an early predictor of therapeutic effects in induction chemotherapy for liver metastases from colorectal cancer.
    Nagai Y; Beppu T; Sakamoto Y; Miyamoto Y; Hayashi H; Nitta H; Imai K; Masuda T; Okabe H; Hirashima K; Imamura Y; Baba Y; Chikamoto A; Baba H
    Anticancer Res; 2014 Oct; 34(10):5529-35. PubMed ID: 25275051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic nomogram for intrahepatic progression-free survival in patients with colorectal liver metastases after ultrasound-guided percutaneous microwave ablation.
    Qin S; Hu H; Cui R; Lin J; Liu Y; Wang Y; Chen Y; Liu G
    Int J Hyperthermia; 2022; 39(1):144-154. PubMed ID: 35012413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.
    Ramphal W; Boeding JRE; van Iwaarden M; Schreinemakers JMJ; Rutten HJT; Crolla RMPH; Gobardhan PD
    Int J Biol Markers; 2019 Mar; 34(1):60-68. PubMed ID: 30852955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic assessment of carcinoembryonic antigen in the first month after liver resection for colorectal liver metastases as a rapid-recurrence predictor.
    Takamoto T; Sugawara Y; Hashimoto T; Shimada K; Inoue K; Maruyama Y; Makuuchi M
    J Surg Oncol; 2016 Mar; 113(4):463-8. PubMed ID: 27100029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes following microwave ablation for liver malignancies.
    Leung U; Kuk D; D'Angelica MI; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; Fong Y
    Br J Surg; 2015 Jan; 102(1):85-91. PubMed ID: 25296639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes following percutaneous microwave ablation for colorectal cancer liver metastases.
    Vogl TJ; Zitsch M; Albrecht M; D'Angelo T; Basten L; Gruber-Rouh T; Nour-Eldin NA; Naguib NNN
    Int J Hyperthermia; 2022; 39(1):788-795. PubMed ID: 35658772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.